Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research10

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research10

FiltersClear all

Status

Recruiting3
Active, not recruiting4
Completed3

Study type

Interventional10

Phase

Not applicable9
Phase 31

Investigator

Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Geoffrey W Bergman6
Shmuel Chen6

Show all 50

Department

Medicine10

Condition

Atrial Fibrillation5
Heart Failure3
Arrhythmias, Cardiac1
Atrial Flutter1
Atrioventricular Block1

Intervention type

Device10
Drug2
Other1
Procedure1

Sponsor type

Industry8
Other academic2

Start date

Has results posted3

Jim W. Cheung×Device×Clear all

Showing 1–10 of 10 studiesSort:

RecruitingInterventional · Not applicableNCT05650658 ↗
Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing With a Left Ventricular Epicardial Lead in Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF)≤50% and With Either a Wide QRS Complex (>130 ms) or With/Anticipated >40% Pacing Randomized Clinical Trial

FiltersClear all

Status

Recruiting3
Active, not recruiting4
Completed3

Study type

Interventional10

Phase

Not applicable9
Phase 31

Investigator

Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Geoffrey W Bergman6
Shmuel Chen6

Show all 50

Department

Medicine10

Condition

Atrial Fibrillation5
Heart Failure3
Arrhythmias, Cardiac1
Atrial Flutter1
Atrioventricular Block1

Intervention type

Device10
Drug2
Other1
Procedure1

Sponsor type

Industry8
Other academic2

Start date

Has results posted3

Jim W. Cheung×Device×Clear all

Showing 1–10 of 10 studiesSort:

RecruitingInterventional · Not applicableNCT05650658 ↗
Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing With a Left Ventricular Epicardial Lead in Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF)≤50% and With Either a Wide QRS Complex (>130 ms) or With/Anticipated >40% Pacing Randomized Clinical Trial

Show fewer

Christopher F Liu5
Conor Liston5
Daniel W Skupski5
Michael G Kaplitt5
Reem Z. Sharaiha5
Manish Ashwin Parikh4
Joan Stilling4
Benjamin Samstein4
Abhishek Jaywant3
Christopher Lau3
David M. Otterburn3
Evelyn M. Horn3
Jared Knopman3
Neel Mehta3
Parag Goyal3
Peter Connolly3
Seth H. Goldbarg3
Shari Lipner3
Stephanie L. Mick3
Steven M Markowitz3
Anna Podolanczuk2
Bradley B Pua2
Gioia Turitto2
Harini Sarva2
Irina Sobol2
Jaikirshan Khatri2
Leonard N Girardi2
Mehraneh Dorna Jafari2
Rajesh Kumar Malik2
Reema Bhatt2
Shing Chiu Wong2
Timothy McClure2
Asad Riaz Siddiqi1
Adam D. Talenfeld1
Anais Rameau1
Anthony O. Ahmed1
Christopher Agrusa1
Cheguevara Afaneh1
Cora Sternberg1
David Leslie Carr-Locke1
Daniel Joseph Holzwanger1
David J Slotwiner1
Darshana M Dadhania1
Dmitriy N. Feldman1
Yuhei Kobayashi1

Show all 9

Show fewer

Cardiovascular Diseases1
Heart Diseases1
Ischemic Stroke1
Tachycardia1

Jim W. CheungPI

Intervention: Device: His/LBBP · Device: BiVP
Dates: Sep 2023 – Jun 2029 (est.)
Sponsor: Baylor College of Medicine

Heart FailureHeart Failure With Reduced Ejection FractionAV Block+4 more

Active, not recruitingInterventional · Not applicableNCT05675865 ↗

Cryoablation for Monomorphic Ventricular Tachycardia IDE Study: EFS and Pivotal

Jim W. CheungPI

Intervention: Device: cryoablation procedure
Dates: Sep 2023 – Jan 2027 (est.)
Sponsor: Adagio Medical

Sustained VT

RecruitingInterventional · Phase 3NCT05836987 ↗

REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Jim W. CheungPIJoonhyuk KimPI

Intervention: Device: AFSW Guided DOAC · Drug: Continuous DOAC therapy
Dates: Jul 2023 – Jul 2029 (est.)
Sponsor: Northwestern University Feinberg School of Medicine

Atrial Fibrillation

Active, not recruitingInterventional · Not applicableNCT06096337 ↗

A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

Jim W. CheungPI

Intervention: Device: FARAPULSE™ Pulsed Field Ablation (PFA) System · Drug: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone
Dates: Dec 2023 – Feb 2026
Sponsor: Boston Scientific Corporation

Persistent Atrial Fibrillation

Active, not recruitingInterventional · Not applicableNCT06735534 ↗

The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters

Jim W. CheungPI

Intervention: Device: FARAPULSE™ Pulsed Field Ablation System
Dates: Jun 2025 – Apr 2027 (est.)
Sponsor: Boston Scientific Corporation

Persistent Atrial Fibrillation

Active, not recruitingInterventional · Not applicableNCT06830746 ↗

A Stylet-Driven ICD Lead Intended for Conduction System Pacing IDE Study

Jim W. CheungPI

Intervention: Device: LBBAP Implant with a CSP ICD Lead
Dates: Apr 2025 – Jan 2026
Sponsor: Abbott Cardiovascular Systems, Inc.

Heart FailureVentricular Arrythmia

RecruitingInterventional · Not applicableNCT07069738 ↗

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

Seth H. GoldbargPIJim W. CheungPI

Intervention: Device: CRT-D with a Quadripolar LV lead · Device: CRT-D with INGEVITY+ pace/sense lead
Dates: Oct 2025 – Nov 2029 (est.)
Sponsor: Boston Scientific Corporation

Heart Failure - NYHA II - IV

CompletedInterventional · Not applicableNCT04060680 ↗

Extravascular ICD Pivotal Study (EV ICD)

Jim W. CheungPI

Intervention: Device: Defibrillation using the Extravascular ICD
Dates: Sep 2019 – Apr 2022· Results posted
Sponsor: Medtronic, Inc.

TachycardiaVentricular Arrythmia

CompletedInterventional · Not applicableNCT04580914 ↗

Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation

Jim W. CheungPI

Intervention: Device: Treatment with IntellaNav StablePoint Ablation Catheter
Dates: Apr 2021 – Jun 2023· Results posted
Sponsor: Boston Scientific Corporation

Paroxysmal Atrial Fibrillation

CompletedInterventional · Not applicableNCT05443594 ↗

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation

Jim W. CheungPI

Intervention: Device: Phase 1: FARAPULSE Ablation System · Device: Phase 2: FARAPULSE Ablation System
Dates: Feb 2023 – Feb 2025· Results posted
Sponsor: Boston Scientific Corporation

Persistent Atrial Fibrillation